Children's Hospital of Philadelphia Selects Affymetrix SNP Array 6.0 for Whole-genome Association Studies
News Jul 26, 2007
Researchers at the Children's Hospital are extending their collaborations to investigators who have preference for the Affymetrix genotyping platform to identify the genes responsible for complex medical disorders, such as cardiovascular, metabolic and central nervous system (CNS) disorders. The results of these studies will enable scientists from around the world to develop more effective, personalized treatments.
The research team at Children's Hospital will use the Affymetrix technology to conduct whole-genome association studies on DNA samples from 7,000 individuals in these early studies.
The Affymetrix SNP Array 6.0 is a single microarray that simultaneously measures more than 1.8 million markers for genetic variation. The array can enable researchers to perform the powerful whole-genome association and copy number studies ever by genotyping more markers across more individuals. These higher-powered studies increase the probability of discovering genes associated with adverse drug response or complex diseases.
"The increased genetic coverage, expanded content and affordability of the Affymetrix SNP Array 6.0 enables us to perform highly powered association and copy number studies, which will provide us with a better understanding of the role of genes and genetic variants in complex diseases," said Hakon Hakonarson, M.D., Ph.D., director of the Center for Applied Genomics at Children's Hospital.
"The results from these projects will open the door to new genetic studies and help us extend current collaborations with other investigators around the world," Hakonarson added.
"For more than 150 years, the Children's Hospital of Philadelphia has made numerous discoveries and innovations that have improved pediatric medicine and helped save lives," said Kevin King, president of life sciences business and executive vice president at Affymetrix.
He continued, "Because of its superior performance, the Affymetrix SNP Array 6.0 is quickly becoming the gold-standard tool for these types of large-scale, whole-genome association studies."
Researchers Discover Mutation That Appears to Protect Against Multiple Aspects of Biological AgingNews
The first genetic mutation that appears to protect against multiple aspects of biological aging in humans has been discovered in an extended family of Old Order Amish living in the vicinity of Berne, Indiana, report Northwestern Medicine scientists.READ MORE
Defects in Cell’s ‘Waste Disposal System’ Linked to Parkinson’sNews
An international study has shed new light on the genetic factors associated with Parkinson’s disease, pointing at a group of lysosomal storage disorder genes as potential major contributors to the onset and progression of this common neurodegenerative disorder.READ MORE
Bioengineered Robotic Hand With Its Own Nervous System Will Sense TouchNews
A team of scientists from Florida Atlantic University are developing a first-of-its-kind bioengineered robotic hand that will grow and adapt to its environment.READ MORE